BACKGROUND: Recurrent venous thromboembolism (VTE) is a common, complex disorder; however, genetic factors have been suggested to play a role in the disease development. We therefore conducted a multi-locus genetic study examining the potential associations of candidate gene variants in inflammation, thrombosis, coagulation, and lipid metabolism pathways, individually or interactively, with risk of recurrent VTE. METHODS: Using DNA samples collected at baseline in the Prevention of Recurrent Venous Thromboembolism trial (PREVENT), we genotyped 86 candidate genes polymorphisms among 43 individuals who subsequently developed recurrent VTE and among 396 individuals who remained free of recurrent event over a mean follow-up period of 2.1 years to prospectively determine whether these gene polymorphisms contribute to the risk of recurrent VTE. RESULTS: Using a single-marker 'uncorrected' analysis, CCR5 A(-2459)G [rs1799864], MMP3 5A(-1171)6A [rs3025058] and PON1 gln192arg [rs662] gene variants were associated with increased risk, and CETP C(-629)A [rs1800775] gene variant with reduced risk of recurrent VTE, respectively. Furthermore, potentially important gene-gene-interactions were detected by the Monte Carlo Markov chain Logic Regression method. CONCLUSIONS: Although the present findings are hypothesis-generating and require confirmation in an independent investigation, our study provides a practical example of detecting epistasis in common, complex diseases.
BACKGROUND: Recurrent venous thromboembolism (VTE) is a common, complex disorder; however, genetic factors have been suggested to play a role in the disease development. We therefore conducted a multi-locus genetic study examining the potential associations of candidate gene variants in inflammation, thrombosis, coagulation, and lipid metabolism pathways, individually or interactively, with risk of recurrent VTE. METHODS: Using DNA samples collected at baseline in the Prevention of Recurrent Venous Thromboembolism trial (PREVENT), we genotyped 86 candidate genes polymorphisms among 43 individuals who subsequently developed recurrent VTE and among 396 individuals who remained free of recurrent event over a mean follow-up period of 2.1 years to prospectively determine whether these gene polymorphisms contribute to the risk of recurrent VTE. RESULTS: Using a single-marker 'uncorrected' analysis, CCR5 A(-2459)G [rs1799864], MMP3 5A(-1171)6A [rs3025058] and PON1 gln192arg [rs662] gene variants were associated with increased risk, and CETP C(-629)A [rs1800775] gene variant with reduced risk of recurrent VTE, respectively. Furthermore, potentially important gene-gene-interactions were detected by the Monte Carlo Markov chain Logic Regression method. CONCLUSIONS: Although the present findings are hypothesis-generating and require confirmation in an independent investigation, our study provides a practical example of detecting epistasis in common, complex diseases.
Authors: S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane Journal: Genome Res Date: 1999-10 Impact factor: 9.043
Authors: C Fatini; F Gensini; E Sticchi; B Battaglini; D Prisco; S Fedi; T Brunelli; R Marcucci; A A Conti; G F Gensini; R Abbate Journal: Eur J Clin Invest Date: 2003-08 Impact factor: 4.686
Authors: Charles Kooperberg; Joshua C Bis; Kristin D Marciante; Susan R Heckbert; Thomas Lumley; Bruce M Psaty Journal: Am J Epidemiol Date: 2006-11-02 Impact factor: 4.897
Authors: Bernd Jilma; Florian M Kovar; Gregor Hron; Georg Endler; Claudia L Marsik; Sabine Eichinger; Paul A Kyrle Journal: Arch Intern Med Date: 2006 Aug 14-28
Authors: Paul M Ridker; Samuel Z Goldhaber; Ellie Danielson; Yves Rosenberg; Charles S Eby; Steven R Deitcher; Mary Cushman; Stephan Moll; Craig M Kessler; C Gregory Elliott; Rolf Paulson; Turnly Wong; Kenneth A Bauer; Bruce A Schwartz; Joseph P Miletich; Henri Bounameaux; Robert J Glynn Journal: N Engl J Med Date: 2003-02-24 Impact factor: 91.245
Authors: Robert Y L Zee; Nancy R Cook; Suzanne Cheng; Rebecca Reynolds; Henry A Erlich; Klaus Lindpaintner; Paul M Ridker Journal: Hum Mol Genet Date: 2003-12-17 Impact factor: 6.150
Authors: Paula M Maeda; Ana Paula S L Bicudo; Renata T M Watanabe; Thais S M Fonseca; Ricardo P do Souto; César E Fernandes; Emerson de Oliveira Journal: Eur J Obstet Gynecol Reprod Biol X Date: 2019-04-30